Outcomes of patients subjected to aortic valve replacement surgery using mechanical or biological prostheses

被引:10
作者
de Almeida, Adriana Silveira [1 ,2 ]
Picon, Paulo Dornelles [1 ]
Belmonte Wender, Orlando Carlos [3 ,4 ,5 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Med Interna, Fac Med, Porto Alegre, RS, Brazil
[2] Hosp Nossa Senhora Conceicao, Grp Hosp Conceicao, Porto Alegre, RS, Brazil
[3] Univ Munique, Alemanha, Brazil
[4] Univ Fed Rio Grande do Sul, Dept Cirurgia, Fac Med, Porto Alegre, RS, Brazil
[5] Hosp Clin Porto Alegre, Serv Cirurgia Cardiovasc, Porto Alegre, RS, Brazil
来源
REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR | 2011年 / 26卷 / 03期
关键词
Bioprosthesis; Heart Valve Prosthesis Implantation; Aortic Valve; Heart Valve Prosthesis; HEART-VALVE; BIOPROSTHETIC VALVE; HOSPITAL MORTALITY; RISK; GUIDELINES; IMPACT; DETERMINANTS; REOPERATION; MORBIDITY; CHOICE;
D O I
10.5935/1678-9741.20110006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This paper evaluates outcomes in patients subjected to surgery for replacement of the aortic valve using biological or mechanical substitutes, where selection of the type of prosthesis is relevant. Methods: Three hundred and one patients, randomly selected, who had been subjected to aortic valve replacement surgery between 1990 and 2005, with a maximum follow-up period of 20 years. Results: Survival at 5, 10 and 15 years after surgery using mechanical substitute was 83.9%, 75.4% and 60.2% and, for biological substitute, was 89.3%, 70.4% and 58.4%, respectively (P=0.939). Factors associated with death were: age, obesity, pulmonary disease, arrhythmia, bleeding and aortic valve failure. Probability free of reoperation for these patients at 5, 10 and 15 years after surgery using mechanical substitute was 97.9%, 95.8% and 95.8% and, for those using bioprostheses, was 94.6%, 91.0% and 83.3%, respectively (P=0.057). Factors associated with reoperation were: renal failure, prosthesis endocarditis and age. Probability free of bleeding events at 5, 10 and 15 years after surgery using mechanical substitute was 94.5%, 91.7% and 91.7% and, for bioprostheses, was 98.6%, 97.8% and 97.8%, respectively (P=0.047). Factors associated with bleeding events were: renal failure and mechanical prostheses. Conclusions: The authors have concluded that: 1) mortality was statistically similar in the groups; 2) patient characteristics at baseline were a major determinant of late mortality after surgery; 3) there was a tendency toward reoperation in the bioprostheses group; 4) patients using mechanical prosthesis had more bleeding events as time passed; 5) data presented in this paper is in accordance with current literature.
引用
收藏
页码:326 / 337
页数:12
相关论文
共 41 条
[1]  
Akins CW, 2008, ANN THORAC SURG, V85, P1490, DOI [10.1016/j.athoracsur.2007.12.082, 10.1016/j.ejcts.2007.12.055]
[2]   Aortic valve replacement in octogenarians [J].
Bose, Amal K. ;
Aitchison, James D. ;
Dark, John H. .
JOURNAL OF CARDIOTHORACIC SURGERY, 2007, 2 (1)
[3]   Aortic valve replacement: an update at the turn of the millennium [J].
Braunwald, E .
EUROPEAN HEART JOURNAL, 2000, 21 (13) :1032-1033
[4]   Aortic valve replacement in patients aged 50 to 70 years: Improved outcome with mechanical versus biologic prostheses [J].
Brown, Morgan L. ;
Schaff, Hartzell V. ;
Lahr, Brian D. ;
Mullany, Charles J. ;
Sundt, Thoralf M. ;
Dearani, Joseph A. ;
McGregor, Christopher G. ;
Orszulak, Thomas A. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 135 (04) :878-884
[5]   Better anticoagulation control improves survival after valve replacement [J].
Butchart, EG ;
Payne, N ;
Li, HH ;
Buchan, K ;
Mandana, K ;
Grunkemeier, GL .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 123 (04) :715-723
[6]   Aortic valve replacement with mechanical and biologic prostheses in middle-aged patients [J].
Carrier, M ;
Pellerin, M ;
Perrault, LP ;
Pagé, P ;
Hébert, Y ;
Cartier, R ;
Dyrda, I ;
Pelletier, LC .
ANNALS OF THORACIC SURGERY, 2001, 71 (05) :S253-S256
[7]  
Carvalho M.H. C., 2005, Arq Bras Cardiol, V84, P3
[8]   The impact of age, coronary artery disease, and cardiac comorbidity on late survival after bioprosthetic aortic valve replacement [J].
Cohen, G ;
David, TE ;
Ivanov, J ;
Armstrong, S ;
Feindel, CM .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 117 (02) :273-282
[9]   Risk factors for hospital mortality in valve replacement with mechanical prosthesis [J].
De Bacco, Mateus W. y ;
Sartori, Ana Paula ;
Michelin Sant'Anna, Jodo Ricardo ;
Santos, Marisa F. ;
Prates, Paulo Roberto ;
Kalil, Renato A. K. ;
Nesralla, Ivo A. .
REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR, 2009, 24 (03) :334-340
[10]   Guidelines for reporting morbidity and mortality after cardiac valvular operations [J].
Edmunds, LH ;
Clark, RE ;
Cohn, LH ;
Grunkemeier, GL ;
Miller, DC ;
Weisel, RD .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (03) :708-711